{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:09:16Z","timestamp":1763507356432,"version":"3.45.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Startup Fund for Scientific Research of Fujian Medical University","award":["No.2022QH1162"],"award-info":[{"award-number":["No.2022QH1162"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["No.2020Y9037"],"award-info":[{"award-number":["No.2020Y9037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-02017-0","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:29:20Z","timestamp":1763461760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated conventional ultrasound and radiomics model for predicting major pathological response to neoadjuvant therapy in triple-negative breast cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Ruoxuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"20","key":"2017_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348.","journal-title":"N Engl J Med"},{"issue":"4","key":"2017_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/jcm12041524","volume":"12","author":"J Lee","year":"2023","unstructured":"Lee J. Current treatment landscape for early Triple-Negative breast cancer (TNBC). J Clin Med. 2023;12(4):1524.","journal-title":"J Clin Med"},{"issue":"5","key":"2017_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.annonc.2024.02.002","volume":"35","author":"L Pusztai","year":"2024","unstructured":"Pusztai L, Denkert C, O\u2019Shaughnessy J, Cortes J, Dent R, McArthur H, et al. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522. Ann Oncol. 2024;35(5):429\u201336.","journal-title":"Ann Oncol"},{"issue":"11","key":"2017_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.annonc.2022.07.1940","volume":"33","author":"S Loibl","year":"2022","unstructured":"Loibl S, Schneeweiss A, Huober J, Braun M, Rey J, Blohmer JU, et al. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response. Ann Oncol. 2022;33(11):1149\u201358.","journal-title":"Ann Oncol"},{"issue":"9938","key":"2017_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164\u201372.","journal-title":"Lancet"},{"issue":"12","key":"2017_CR6","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","volume":"25","author":"Z Liu","year":"2019","unstructured":"Liu Z, Li Z, Qu J. Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: A multicenter study. Clin Cancer Res. 2019;25(12):3538\u201347.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2017_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12094-019-02109-8","volume":"22","author":"Q Xiong","year":"2020","unstructured":"Xiong Q, Zhou X, Liu Z, Lei C, Yang C, Yang M, et al. Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy. Clin Transl Oncol. 2020;22(1):50\u20139.","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"2017_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1148\/rg.336125060","volume":"33","author":"JS Ecanow","year":"2013","unstructured":"Ecanow JS, Abe H, Newstead GM, Ecanow DB, Jeske JM. Axillary staging of breast cancer: what the radiologist should know. Radiographics. 2013;33(6):1589\u2013612.","journal-title":"Radiographics"},{"issue":"5","key":"2017_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12(5):320\u20137.","journal-title":"Breast"},{"key":"2017_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","volume":"147","author":"M Jiang","year":"2021","unstructured":"Jiang M, Li C-L, Luo X-M, Chuan Z-R, Lv W-Z, Li X, et al. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer. Eur J Cancer. 2021;147:95\u2013105.","journal-title":"Eur J Cancer"},{"issue":"8","key":"2017_CR11","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.7314\/APJCP.2015.16.8.3229","volume":"16","author":"Q Yang","year":"2015","unstructured":"Yang Q, Liu HY, Liu D, Song YQ. Ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes. Asian Pac J Cancer Prev. 2015;16(8):3229\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"2017_CR12","first-page":"193","volume":"26","author":"W Lohitvisate","year":"2023","unstructured":"Lohitvisate W, Pummee N, Kwankua A. Mammographic and ultrasonographic features of triple-negative breast cancer compared with non-triple-negative breast cancer. J Ultrasound. 2023;26(1):193\u2013200.","journal-title":"J Ultrasound"},{"issue":"8","key":"2017_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/0284185113488580","volume":"54","author":"MY Kim","year":"2013","unstructured":"Kim MY, Choi N. Mammographic and ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes. Acta Radiol. 2013;54(8):889\u201394.","journal-title":"Acta Radiol"},{"issue":"3","key":"2017_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jum.16377","volume":"43","author":"L Cai","year":"2024","unstructured":"Cai L, Sidey-Gibbons C, Nees J, Riedel F, Schaefgen B, Togawa R, et al. Ultrasound radiomics features to identify patients with Triple-Negative breast cancer: A Retrospective, Single-Center study. J Ultrasound Med. 2024;43(3):467\u201378.","journal-title":"J Ultrasound Med"},{"issue":"10","key":"2017_CR15","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.7863\/jum.2012.31.10.1531","volume":"31","author":"S Wojcinski","year":"2012","unstructured":"Wojcinski S, Soliman AA, Schmidt J, Makowski L, Degenhardt F, Hillemanns P. Sonographic features of triple-negative and non-triple-negative breast cancer. J Ultrasound Med. 2012;31(10):1531\u201341.","journal-title":"J Ultrasound Med"},{"issue":"4","key":"2017_CR16","first-page":"373","volume":"47","author":"CLMY Yang","year":"2024","unstructured":"Yang CLMY, Wang J, Sun CJ, Zhang Q. Predictive value of ultrasonic features and immunohistochemical markers for pathological complete response of axillary lymph nodes after neoadjuvant therapy in breast cancer. J Mol Imaging. 2024;47(4):373\u20138.","journal-title":"J Mol Imaging"},{"issue":"5","key":"2017_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41563-023-01716-9","volume":"23","author":"J Chang","year":"2024","unstructured":"Chang J, Saraswathibhatla A. Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancer. Nat Mater. 2024;23(5):711\u201322.","journal-title":"Nat Mater"},{"issue":"15","key":"2017_CR18","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796\u2013804.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2017_CR19","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR, Andr\u00e9 F, Tordai A, Mejia JA, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275\u201381.","journal-title":"J Clin Oncol"},{"issue":"16","key":"2017_CR20","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1002\/cam4.3255","volume":"9","author":"D DiCenzo","year":"2020","unstructured":"DiCenzo D, Quiaoit K, Fatima K, Bhardwaj D, Sannachi L, Gangeh M, et al. Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: results from multi-institutional study. Cancer Med. 2020;9(16):5798\u2013806.","journal-title":"Cancer Med"},{"issue":"2","key":"2017_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1148\/radiol.2017170143","volume":"286","author":"F Chamming\u2019s","year":"2018","unstructured":"Chamming\u2019s F, Ueno Y, Ferr\u00e9 R, Kao E, Jannot AS, Chong J, et al. Features from computerized texture analysis of breast cancers at pretreatment MR imaging are associated with response to neoadjuvant chemotherapy. Radiology. 2018;286(2):412\u201320.","journal-title":"Radiology"},{"issue":"3","key":"2017_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/tbj.13032","volume":"25","author":"HJ Yoon","year":"2019","unstructured":"Yoon HJ, Kim Y, Chung J, Kim BS. Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET\/CT and diffusion-weighted MR imaging. Breast J. 2019;25(3):373\u201380.","journal-title":"Breast J"},{"key":"2017_CR23","doi-asserted-by":"crossref","unstructured":"Granzier RWY, Ibrahim A. MRI-based radiomics analysis for the pretreatment prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients: a multicenter study. Cancers (Basel) 2021;13(10).","DOI":"10.3390\/cancers13102447"},{"issue":"3","key":"2017_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.34540","volume":"129","author":"J Gu","year":"2023","unstructured":"Gu J, Tong T, Xu D, Cheng F, Fang C, He C, et al. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study. Cancer. 2023;129(3):356\u201366.","journal-title":"Cancer"},{"key":"2017_CR25","doi-asserted-by":"publisher","first-page":"101899","DOI":"10.1016\/j.eclinm.2023.101899","volume":"58","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhu T, Zhang X, Li W, Zheng X, Cheng M, et al. Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study. EClinicalMedicine. 2023;58:101899.","journal-title":"EClinicalMedicine"},{"key":"2017_CR26","doi-asserted-by":"crossref","unstructured":"Li F, Wei Y, Li L, Chen F, Bao C, Bu H et al. Collagen density is associated with pathological complete response to neoadjuvant chemotherapy in Triple-Negative breast cancer patients. J Surg Oncol. 2024.","DOI":"10.1002\/jso.28046"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02017-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:06:17Z","timestamp":1763507177000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-02017-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02017-0","relation":{},"ISSN":["1471-2342"],"issn-type":[{"type":"electronic","value":"1471-2342"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (approval number K2023-109-01), while an informed consent was obtained from all individual participants. The study was conducted in accordance with the Declaration of Helsinki. All methods were performed in accordance with the relevant guidelines and regulations of the National Health Commission of the People\u2019s Republic of China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}